138 related articles for article (PubMed ID: 10926893)
1. Evidence-based implementation of free phenytoin therapeutic drug monitoring.
Burt M; Anderson DC; Kloss J; Apple FS
Clin Chem; 2000 Aug; 46(8 Pt 1):1132-5. PubMed ID: 10926893
[TBL] [Abstract][Full Text] [Related]
2. Utility of free level monitoring of antiepileptic drugs.
Levy RH; Schmidt D
Epilepsia; 1985; 26(3):199-205. PubMed ID: 3924585
[TBL] [Abstract][Full Text] [Related]
3. Predicting Unbound Phenytoin Concentrations: Effects of Albumin Concentration and Kidney Dysfunction.
Montgomery MC; Chou JW; McPharlin TO; Baird GS; Anderson GD
Pharmacotherapy; 2019 Jul; 39(7):756-766. PubMed ID: 31067355
[TBL] [Abstract][Full Text] [Related]
4. Free level monitoring of antiepileptic drugs. Clinical usefulness and case studies.
Perucca E
Clin Pharmacokinet; 1984 Jan; 9 Suppl 1():71-8. PubMed ID: 6423336
[TBL] [Abstract][Full Text] [Related]
5. Interpatient and intrapatient variability in phenytoin protein binding.
Banh HL; Burton ME; Sperling MR
Ther Drug Monit; 2002 Jun; 24(3):379-85. PubMed ID: 12021629
[TBL] [Abstract][Full Text] [Related]
6. Clinical decision support of therapeutic drug monitoring of phenytoin: measured versus adjusted phenytoin plasma concentrations.
Krasowski MD; Penrod LE
BMC Med Inform Decis Mak; 2012 Feb; 12():7. PubMed ID: 22333264
[TBL] [Abstract][Full Text] [Related]
7. Free phenytoin assessment in patients: measured versus calculated blood serum levels.
Tobler A; Hösli R; Mühlebach S; Huber A
Int J Clin Pharm; 2016 Apr; 38(2):303-9. PubMed ID: 26746902
[TBL] [Abstract][Full Text] [Related]
8. Correlation of Free and Total Phenytoin Serum Concentrations in Critically Ill Patients.
Buckley MS; Reeves BA; Barletta JF; Bikin DS
Ann Pharmacother; 2016 Apr; 50(4):276-81. PubMed ID: 26783351
[TBL] [Abstract][Full Text] [Related]
9. Interaction between vigabatrin and phenytoin.
Rimmer EM; Richens A
Br J Clin Pharmacol; 1989; 27 Suppl 1(Suppl 1):27S-33S. PubMed ID: 2757906
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic drug monitoring of phenytoin in critically ill patients.
von Winckelmann SL; Spriet I; Willems L
Pharmacotherapy; 2008 Nov; 28(11):1391-400. PubMed ID: 18956999
[TBL] [Abstract][Full Text] [Related]
11. Total phenytoin concentrations do not accurately predict free phenytoin concentrations in critically ill children.
Wolf GK; McClain CD; Zurakowski D; Dodson B; McManus ML
Pediatr Crit Care Med; 2006 Sep; 7(5):434-9; quiz 440. PubMed ID: 16885794
[TBL] [Abstract][Full Text] [Related]
12. Phenytoin-oxacillin interactions in normal and uremic sera.
Dasgupta A; Sperelakis A; Mason A; Dean R
Pharmacotherapy; 1997; 17(2):375-8. PubMed ID: 9085332
[TBL] [Abstract][Full Text] [Related]
13. [Severe phenytoin intoxication in patients with hypoalbuminaemia].
Kemper EM; van Kan HJ; Speelman P; de Gans K; Beijnen JH; Schellens JH
Ned Tijdschr Geneeskd; 2007 Jan; 151(2):138-41. PubMed ID: 17315493
[TBL] [Abstract][Full Text] [Related]
14. Practical problems of therapeutic drug monitoring of anticonvulsants.
Walson PD
Brain Dev; 1985; 7(2):116-21. PubMed ID: 4014608
[No Abstract] [Full Text] [Related]
15. Therapeutic drug monitoring of antiepileptic drugs.
Shakya G; Malla S; Shakya KN; Shrestha R
JNMA J Nepal Med Assoc; 2008; 47(171):94-7. PubMed ID: 19079370
[TBL] [Abstract][Full Text] [Related]
16. Effect of sex on serum protein binding characteristics of phenytoin in pediatric patients with epilepsy.
Kodama H; Kodama Y; Itokazu N; Arimori K; Kanemaru R; Sugimoto T; Fujimura A
Am J Health Syst Pharm; 2000 Jun; 57(12):1144-7. PubMed ID: 10911514
[No Abstract] [Full Text] [Related]
17. Effect of temperature on serum protein binding characteristics of phenytoin in monotherapy paediatric patients with epilepsy.
Kodama H; Kodama Y; Itokazu N; Shinozawa S; Kanemaru R; Sugimoto T
J Clin Pharm Ther; 2001 Jun; 26(3):175-9. PubMed ID: 11422600
[TBL] [Abstract][Full Text] [Related]
18. Clinical utility of free drug monitoring.
Dasgupta A
Clin Chem Lab Med; 2002 Oct; 40(10):986-93. PubMed ID: 12476936
[TBL] [Abstract][Full Text] [Related]
19. Binding of fosphenytoin, phosphate ester pro drug of phenytoin, to human serum proteins and competitive binding with carbamazepine, diazepam, phenobarbital, phenylbutazone, phenytoin, valproic acid or warfarin.
Lai CM; Moore P; Quon CY
Res Commun Mol Pathol Pharmacol; 1995 Apr; 88(1):51-62. PubMed ID: 7620838
[TBL] [Abstract][Full Text] [Related]
20. The EMIT FreeLevel ultrafiltration technique compared with equilibrium dialysis and ultracentrifugation to determine protein binding of phenytoin.
Oellerich M; Müller-Vahl H
Clin Pharmacokinet; 1984 Jan; 9 Suppl 1():61-70. PubMed ID: 6705428
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
